Skip to content
healthcare.dev

AMVUTTRA

NDC 71336-1003, VUTRISIRAN, injection, from Alnylam Pharmaceuticals, Inc..

Product NDC
71336-1003
Status
Listed
Labeler
Alnylam Pharmaceuticals, Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215515
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71336-1003 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VUTRISIRAN SODIUM25 mg/.5mL

Pharmacologic classes

Decreased RNA Integrity [PE]; Increased Protein Breakdown [PE]; RNA, Small Interfering [CS]; Small Interfering RNA [EPC]; Transthyretin-directed RNA Interaction [EPC]

Package NDCNDC-11Package
71336-1003-1713361003011 SYRINGE, GLASS in 1 CARTON (71336-1003-1) / .5 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8db0facb-81b6-4006-9239-27dc6409c5d3
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=71336-1003

Use it

Look up 71336-1003 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71336-1003 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71336-1003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.